Advertisement

Topics

Akebia nets $54.5mm through public stock sale

15:40 EDT 30 Jun 2017 | Elsevier Business Intelligence

Akebia Therapeutics Inc. (kidney and GI therapies based on hypoxia-inducible factor biology) netted $54.5mm through the publi...

Original Article: Akebia nets $54.5mm through public stock sale

NEXT ARTICLE

More From BioPortfolio on "Akebia nets $54.5mm through public stock sale"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...